Bio-TechneMEX:TECH 83 Gross Margin % is 66.88% as of Mar. 2026, which is 0% above its 10-year median of 66.87. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,117.60. The stock has 8 warning signs investors should review. Among 737 Biotechnology companies, Bio-Techne ranks better than 54.68% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Bio-Techne's Gross Profit for the
three
months ended in Mar. 2026 was MXN3,756 Mil. Bio-Techne's Revenue for the
three
months ended in Mar. 2026 was MXN5,616 Mil. Therefore, Bio-Techne's Gross Margin % for the quarter that ended in Mar. 2026 was 66.88%.
The historical rank and industry rank for Bio-Techne's Gross Margin % or its related term are showing as below:
MEX:TECH'
s Gross Margin % Range Over the Past 10 Years
Min: 64.8 Med: 66.87 Max: 68.42
Current: 64.96
During the past 13 years, the highestGross Margin % of Bio-Techne was 68.42%. The lowest was 64.80%. And the median was 66.87%.
MEX:TECH's Gross Margin % is ranked better than 54.68% of 737
companies
in the Biotechnology industry
Industry Median: 60.92
vs MEX:TECH: 64.96
Bio-Techne had a gross margin of 66.88% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bio-Techne was -0.40% per year.
Bio-Techne (MEX:TECH) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bio-Techne had a gross margin of 66.88% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bio-Techne Gross Margin % Related Terms
Bio-Techne Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bio-Techne's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TECH vs HALO, IBRX, NUVL: Gross Margin % Comparison
For the Biotechnology subindustry, Bio-Techne's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bio-Techne (MEX:TECH) has a Gross Margin % of 66.88% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Bio-Techne and its competitors. This is near median its historical median of 66.87. Over the past decade, Bio-Techne's Gross Margin % has ranged from 64.80 to 68.42. According to the industry distribution chart, Bio-Techne ranks #334 out of 737 companies in the Biotechnology industry, placing it in the top 45.3%.
Is Bio-Techne's Gross Margin % too high?
Bio-Techne's current Gross Margin % of 66.88% is near median its 10-year median of 66.87. Over the past 10 years, this metric has ranged from a low of 64.80 to a high of 68.42. The Biotechnology industry median Gross Margin % is 60.92. Bio-Techne's value of 66.88% is 9.8% above this industry median. Based on the distribution chart, Bio-Techne ranks #334 out of 737 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Gross Margin % compare to HALO and IBRX?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #334 out of 737 companies for Gross Margin %. This puts Bio-Techne in the upper half of its industry. The industry median Gross Margin % is 60.92. Bio-Techne's value of 66.88% is 9.8% above this benchmark. Historically, Bio-Techne's own Gross Margin % has ranged from 64.80 to 68.42 over the past decade. While the company's 10-year median is 66.87 vs. the industry median of 60.92, Bio-Techne has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.92, based on 737 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio-Techne's current Gross Margin % of 66.88% is 9.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bio-Techne and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Techne's current Gross Margin % is 66.88%, which is near median its own 10-year median of 66.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current Gross Margin % of 66.88%. The stock's GF Value™ is MXN1,117.60, compared to a current price of MXN1,090.00 — trading 2.5% below its estimated fair value. The current Gross Margin % is 66.88%, which is near median its 10-year median of 66.87 and 9.8% above the Biotechnology industry median of 60.92. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current Gross Margin % is 66.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of MXN1,090.00 is trading 2.5% below its estimated GF Value™ of MXN1,117.60.
Key valuation signals for MEX:TECH:
Gross Margin %: 66.88% (near median its 10-year median of 66.87)
GF Value™: MXN1,117.60 vs. price of MXN1,090.00 (2.5% below fair value)
Industry Position: 9.8% above the Biotechnology median (#334 of 737)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score
Get the complete analysis for MEX:TECH
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
